<DOC>
	<DOCNO>NCT02153086</DOCNO>
	<brief_summary>The purpose survey examine safety efficacy long-term use ramelteon tablet ( Rozerem 8 mg Tablets ) participant difficulty fall asleep associate insomnia daily medical practice .</brief_summary>
	<brief_title>Ramelteon 8 mg Tablets Specified Drug-use Survey : &lt; Long-term Survey Insomnia Accompanied Difficulty Falling Asleep &gt; − Transitional Survey From Preceding Drug-use Survey −</brief_title>
	<detailed_description>This survey design examine safety efficacy long-term use ramelteon tablet ( Rozerem 8 mg Tablets ) participant difficulty fall asleep associate insomnia daily medical practice.The usual dosage adult 8 mg ramelteon administer orally daily bedtime .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Participants difficulty fall asleep associate insomnia complete 4week followup precede drug use surveillance able receive continuous administration Rozerem Tablets Participants contraindication Rozerem Tablets . Participants previous history hypersensitivity ingredient Rozerem Tablets . Participants severe liver dysfunction . Participants take fluvoxamine maleate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>